We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BBNI:IDXPT Bank Negara Indonesia (Persero) Tbk Class B Analysis

Data as of 2026-06-20 - not real-time

IDR 3,670.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Bank Negara Indonesia is trading at IDR 3,670, well below its 20‑day SMA of 3,622 and 50‑day SMA of 3,724, indicating a short‑term bearish bias, yet the MACD histogram is positive (+37.5) and the signal line has turned bullish, suggesting a potential technical rebound. The RSI sits around 50, reflecting a neutral momentum, while volume is on an increasing trend, supporting the possibility of renewed buying pressure. Valuation metrics are compelling: a trailing P/E of 6.73 versus the industry average of 16.9 and a P/B of 0.85 signal that the stock is markedly undervalued, with an upside potential of roughly 30% based on analyst targets.
Fundamentally, the bank delivers strong profitability with an operating margin of 47% and a profit margin of 40%, and its ROE of 12% underscores efficient capital use despite a modest beta of 0.21 indicating low market volatility. However, the 30‑day volatility of 54% and a max drawdown near 35% highlight notable price swings, and the absence of dividend payments removes income stability, making the case for capital‑gain focused investors.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Positive MACD histogram indicating bullish momentum
  • Increasing trading volume supporting price support
  • Significant valuation discount (low P/E and P/B)

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus strong‑buy with median price target of IDR 4,800
  • Robust profitability margins and solid ROE
  • Undervalued relative to industry peers offering ~30% upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Stable low‑beta profile reducing market risk
  • Strategic expansion through BNI Multifinance and digital platforms
  • Strong capital position and low debt‑to‑equity ratio

Key Metrics & Analysis

Financial Health

Revenue Growth7.80%
Profit Margin40.03%
P/E Ratio6.7
ROE12.03%
ROA1.58%
P/B Ratio0.8
Op. Cash FlowIDR-148624340156416
Industry P/E16.9

Technical Analysis

TrendBearish
RSI50.5
SupportIDR 2,990.00
ResistanceIDR 3,930.00
MA 20IDR 3,622.00
MA 50IDR 3,724.80
MA 200IDR 4,152.40
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Target PriceIDR 4,755.32
Upside/Downside29.57%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.21
Volatility54.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.